Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 8 | 2022 | 35 | 3.100 |
Why?
|
| Fontan Procedure | 5 | 2022 | 14 | 2.060 |
Why?
|
| Cardiac Catheterization | 9 | 2018 | 70 | 1.680 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2018 | 17 | 1.480 |
Why?
|
| Ultrasonography, Interventional | 4 | 2014 | 74 | 1.310 |
Why?
|
| Heart Ventricles | 8 | 2018 | 101 | 1.240 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2017 | 28 | 1.200 |
Why?
|
| Echocardiography | 7 | 2018 | 91 | 1.190 |
Why?
|
| Mammary Arteries | 2 | 2018 | 9 | 1.150 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2017 | 13 | 0.840 |
Why?
|
| Tertiary Care Centers | 2 | 2013 | 67 | 0.840 |
Why?
|
| Heart Block | 2 | 2017 | 7 | 0.710 |
Why?
|
| Tachycardia | 1 | 2018 | 10 | 0.630 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2009 | 39 | 0.600 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2017 | 1 | 0.600 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2017 | 3 | 0.600 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2017 | 8 | 0.600 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 60 | 0.580 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 13 | 0.580 |
Why?
|
| Feces | 1 | 2017 | 107 | 0.570 |
Why?
|
| Child, Preschool | 7 | 2018 | 678 | 0.570 |
Why?
|
| Coronary Sinus | 1 | 2017 | 4 | 0.570 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 5 | 0.570 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 10 | 0.560 |
Why?
|
| Female | 19 | 2022 | 15534 | 0.560 |
Why?
|
| Coronary Disease | 2 | 2014 | 57 | 0.550 |
Why?
|
| Humans | 27 | 2022 | 28054 | 0.540 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 87 | 0.530 |
Why?
|
| Child | 8 | 2022 | 1407 | 0.520 |
Why?
|
| Infant, Newborn | 7 | 2018 | 605 | 0.510 |
Why?
|
| Prenatal Diagnosis | 2 | 2013 | 18 | 0.510 |
Why?
|
| Heart Atria | 4 | 2018 | 28 | 0.490 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 9 | 0.470 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 13 | 0.470 |
Why?
|
| Pulmonary Valve | 1 | 2014 | 12 | 0.470 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 22 | 0.470 |
Why?
|
| Pregnancy | 5 | 2014 | 337 | 0.460 |
Why?
|
| Heart Neoplasms | 1 | 2014 | 12 | 0.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 28 | 0.450 |
Why?
|
| Osteosarcoma | 1 | 2014 | 36 | 0.450 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 3 | 0.430 |
Why?
|
| Fetal Heart | 1 | 2013 | 2 | 0.430 |
Why?
|
| Ventricular Function | 1 | 2013 | 8 | 0.430 |
Why?
|
| Pentalogy of Cantrell | 1 | 2013 | 2 | 0.430 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 11 | 0.430 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 41 | 0.420 |
Why?
|
| Male | 17 | 2018 | 15143 | 0.420 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 120 | 0.410 |
Why?
|
| Levocardia | 1 | 2012 | 1 | 0.410 |
Why?
|
| Balloon Occlusion | 2 | 2009 | 9 | 0.370 |
Why?
|
| Femur | 1 | 2014 | 392 | 0.360 |
Why?
|
| Retrospective Studies | 8 | 2018 | 3524 | 0.340 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 78 | 0.340 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 22 | 0.310 |
Why?
|
| Adolescent | 6 | 2022 | 2289 | 0.310 |
Why?
|
| Treatment Outcome | 6 | 2018 | 3530 | 0.310 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 370 | 0.300 |
Why?
|
| Coronary Circulation | 3 | 2014 | 25 | 0.270 |
Why?
|
| Heart Failure | 3 | 2014 | 173 | 0.270 |
Why?
|
| Infant | 4 | 2018 | 566 | 0.270 |
Why?
|
| Coronary Artery Bypass | 2 | 2016 | 27 | 0.250 |
Why?
|
| Palliative Care | 2 | 2017 | 109 | 0.240 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 1809 | 0.230 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2014 | 8 | 0.220 |
Why?
|
| Myocytes, Cardiac | 2 | 2014 | 92 | 0.220 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 32 | 0.200 |
Why?
|
| Oxygen | 1 | 2022 | 80 | 0.190 |
Why?
|
| Exercise Test | 1 | 2022 | 121 | 0.190 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 39 | 0.180 |
Why?
|
| Adult | 4 | 2017 | 8021 | 0.170 |
Why?
|
| Young Adult | 3 | 2017 | 2043 | 0.170 |
Why?
|
| Pulmonary Artery | 2 | 2017 | 44 | 0.160 |
Why?
|
| Tetralogy of Fallot | 1 | 2018 | 5 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 43 | 0.150 |
Why?
|
| Biomarkers | 2 | 2017 | 581 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 928 | 0.150 |
Why?
|
| Equipment Design | 2 | 2008 | 153 | 0.150 |
Why?
|
| Atrial Pressure | 1 | 2017 | 2 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 4 | 0.140 |
Why?
|
| Vascular Resistance | 1 | 2017 | 13 | 0.140 |
Why?
|
| Hemodynamics | 3 | 2018 | 68 | 0.140 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2017 | 1 | 0.140 |
Why?
|
| Alprostadil | 1 | 2017 | 10 | 0.140 |
Why?
|
| Stents | 2 | 2015 | 85 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2018 | 187 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2018 | 125 | 0.140 |
Why?
|
| Quality of Life | 1 | 2022 | 655 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2017 | 30 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 30 | 0.140 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2016 | 4 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 138 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2016 | 34 | 0.130 |
Why?
|
| Norwood Procedures | 1 | 2015 | 7 | 0.130 |
Why?
|
| Collateral Circulation | 1 | 2014 | 5 | 0.120 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2014 | 17 | 0.120 |
Why?
|
| Excitation Contraction Coupling | 1 | 2014 | 12 | 0.120 |
Why?
|
| Diverticulum | 1 | 2014 | 4 | 0.120 |
Why?
|
| Heart Aneurysm | 1 | 2014 | 8 | 0.120 |
Why?
|
| Ventricular Septum | 1 | 2014 | 1 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2014 | 32 | 0.120 |
Why?
|
| Electrocardiography | 2 | 2012 | 109 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2014 | 57 | 0.120 |
Why?
|
| Urocortins | 1 | 2014 | 1 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 10 | 0.110 |
Why?
|
| Biopsy | 1 | 2014 | 218 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2014 | 118 | 0.110 |
Why?
|
| Pharmacopoeias as Topic | 1 | 2012 | 6 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 201 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 28 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 14 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2017 | 1882 | 0.100 |
Why?
|
| Pediatrics | 1 | 2012 | 47 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2014 | 501 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2012 | 68 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 313 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 758 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 18 | 0.080 |
Why?
|
| Dilatation, Pathologic | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 32 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 23 | 0.080 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2009 | 8 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 17 | 0.080 |
Why?
|
| Cineangiography | 1 | 2008 | 2 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 39 | 0.080 |
Why?
|
| Forecasting | 1 | 2009 | 102 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2008 | 76 | 0.080 |
Why?
|
| Aortography | 1 | 2007 | 6 | 0.070 |
Why?
|
| Phlebography | 1 | 2007 | 9 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 511 | 0.070 |
Why?
|
| Middle Aged | 2 | 2013 | 9186 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2007 | 27 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2007 | 231 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 718 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2009 | 664 | 0.070 |
Why?
|
| Rabbits | 2 | 2014 | 193 | 0.060 |
Why?
|
| Time Factors | 1 | 2007 | 1485 | 0.050 |
Why?
|
| Animals | 3 | 2014 | 3824 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 45 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 2 | 0.040 |
Why?
|
| Telemetry | 1 | 2017 | 11 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 53 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 27 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 24 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2014 | 29 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 47 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 10 | 0.030 |
Why?
|
| Aged | 1 | 2007 | 9222 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 44 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 80 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 327 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 51 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 492 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 539 | 0.030 |
Why?
|
| Cardiology | 1 | 2012 | 55 | 0.020 |
Why?
|
| Disease Management | 1 | 2012 | 114 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 818 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 377 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 455 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 633 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 2 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 67 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 170 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2009 | 72 | 0.020 |
Why?
|